← FDA Drug Approvals (Drugs@FDA)
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2022-06-29
Drug application
- FDA Application #
ANDA215370- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
- Generic name
- SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE
- Active ingredients
- MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2022-06-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown